The OxyContin maker filed its long-awaited restructuring plan in bankruptcy court. Revenue from the new company would go exclusively to abating the opioid crisis.
from NYT > Health https://ift.tt/3bRljjG
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment